The International Vaccine Institute (IVI) and Egyptian Agency for Partnership for Development (EAPD) are co-hosting a symposium to support the advancement of vaccine manufacturing capacity in Africa.
Building regional capacity has become a critical priority amid the COVID-19 pandemic, leading the World Health Assembly to pass a resolution last year calling for the strengthening of local production of medicines and other health technologies. Additionally, the African Union and Africa CDC launched the Partnerships for African Vaccine Manufacturing framework to expand Africa’s vaccine manufacturing capacity for health security.
We will review the challenges and opportunities for vaccine manufacturing in Africa and present practical guidance and lessons learned from building vaccine manufacturing capacity in resource-limited settings. A panel discussion featuring experts from global health funding agencies, vaccine R&D institutes, and developing country vaccine manufacturers will explore the pathway to building a sustainable business model for African vaccine manufacturers.
The webinar will be in English with simultaneous interpretation in Arabic and French, and will be moderated by Dr. Birkneh Tilahun Tadesse, Senior Research Scientist, IVI.
Moderated by Dr. Youngmee Jee, Chief Executive Officer, Institut Pasteur Korea